Why eating less stops working

The scales haven't moved. The portion sizes are smaller, the wine is rationed, and the mid-morning biscuit has been replaced with virtue. Yet something underneath the effort has quietly shifted — the body no longer responds the way it did at 35.

This is not a discipline problem. After 40, the machinery that governs hunger and metabolism begins to change independently of what anyone decides to eat. Three interlocking hormonal systems — ghrelin, which fires the appetite signal from the stomach lining; leptin, which is supposed to tell the brain when enough is enough; and the thyroid hormones that set the pace of calorie-burning — all drift in ways that create a widening gap between what the body signals and what it actually needs.

In Professor Paul Lee's Regeneration by Design framework, this sits squarely within the Chemistry pillar: the body's internal hormonal environment is as much a target for active design as exercise or nutrition. Understanding how these three systems shift — and why they shift together — is the first step towards working with them rather than against them.

Ghrelin — the hunger signal that outlasts its welcome

Every few hours, the stomach lining releases a burst of ghrelin — a peptide hormone that travels to the hypothalamus and, via the GHS-R receptor, fires the drive to eat. Blood levels peak sharply in the hour before a meal, then fall once food arrives. It is a clean, purposeful rhythm — except that age begins to distort it.

Early research in animal models suggests that GHS-R does more than regulate appetite: it also shapes gut inflammation and microbiome balance. Aged mice lacking the receptor developed a disease-susceptible microbial profile — more Firmicutes, fewer Bacteroidetes — and showed worsened intestinal inflammation. Whether the same shifts occur in ageing humans at the same scale remains to be confirmed, but the findings place ghrelin within the gut–brain–metabolism axis, not simply at the dinner table.

There is also a less obvious member of the ghrelin family worth knowing. Unacylated ghrelin (UnAG) — the non-hunger form — does not stimulate appetite. Animal studies show it can preserve skeletal muscle and promote a more oxidative metabolism in ageing tissue, making it a counterintuitive candidate for sarcopenia-prevention research, entirely separate from ghrelin's better-known role as a hunger trigger.

Ghrelin's responsiveness also appears to blunt with age: LEAP-2, a natural ghrelin antagonist, shows reduced efficacy in ageing animal models, hinting that the pathway itself becomes less reactive over time.

None of this operates in isolation. Ghrelin's appetite signal becomes genuinely difficult to override only when leptin — the distinct satiety hormone that should prompt the brain to stop eating — has already begun to fall silent.

Leptin resistance — a satiety signal the brain stops hearing

The satiety hormone leptin does not diminish after 40 — if anything, it tends to rise as fat mass increases. The problem is that the brain stops responding to it.

Leptin is released by fat cells to inform the hypothalamus that energy stores are adequate, dampening appetite and nudging energy expenditure upward. In leptin resistance — the signature midlife dysfunction — the signal is broadcast at full volume and received as silence. Research published in 2002 confirmed that this resistance is independent of fat mass: the brain's blunted sensitivity is a feature of the ageing process itself, not merely a downstream consequence of carrying extra weight.

One plausible cellular mechanism, identified in animal models, involves rising skeletal glucocorticoid signalling with age. When researchers blocked this pathway in mice, the animals remained lean, insulin-sensitive, and leptin-responsive throughout ageing, whereas their normal counterparts developed obesity and impaired hypothalamic responses from as early as six months. The human translation remains under investigation, but it offers a concrete explanation for why leptin resistance can feel structurally built into midlife biology.

Declining oestrogen and testosterone compound the picture, further blunting leptin sensitivity and steering fat storage towards the abdomen — a shift that many people in their forties recognise without yet understanding its hormonal origin.

In the Chemistry pillar of Regeneration by Design, this is framed not as a failure of discipline but as a communication breakdown in the body's internal signalling environment: high circulating leptin, insensitive hypothalamus — the satiety signal sent but not received.

The thyroid layer — when conversion, not production, is the problem

Standard thyroid blood tests return a TSH figure — thyroid-stimulating hormone — and for most adults that single number is treated as the whole story. It often is not.

TSH measures the brain's demand for thyroid output, not what the thyroid actually delivers to cells. The hormone doing metabolic work is free T3, converted from the more abundant T4. That conversion step is where midlife biology quietly stumbles: free T3 falls progressively with age even when T4 remains stable, signalling a real functional slowdown that a TSH reading alone may not capture. The complication is that the reference ranges used in standard panels are not yet age-adjusted — so a result that registers as borderline-normal in a 50-year-old may represent a meaningful functional change relative to their own prior baseline.

The cellular picture, emerging from single-cell RNA sequencing of human thyroid tissue, is more specific than a simple hormonal drift. Subclinical hypothyroidism in midlife appears to involve a distinct subpopulation of thyroid epithelial cells showing mitochondrial dysfunction, inflammation, and fibrosis — the same cellular themes that surface in the Biology pillar's broader account of tissue ageing. It helps explain why some people experience genuine metabolic drag — reduced thermogenesis, fatigue, difficulty managing weight — against a backdrop of test results that look broadly acceptable.

For middle-aged individuals with low-normal thyroid function, research suggests an increased risk of cardiovascular and metabolic complications. TSH levels begin rising from around age 50 in women and 60 in men — a shift that standard panels, calibrated to a single adult reference range, are not designed to flag. In the Time pillar of Regeneration by Design, this makes proactive thyroid monitoring a textbook early-action move: acting in the window where the margin for adjustment is still wide.

Sleep — the amplifier that makes everything worse

There is a mechanism that can quietly undo whatever progress ghrelin management and leptin sensitivity work might otherwise achieve: insufficient sleep.

Fewer than seven hours a night simultaneously raises ghrelin, suppresses leptin, and elevates cortisol — a triple hormonal hit that pushes the body into a state of manufactured hunger. Research from Stanford Lifestyle Medicine links this pattern to a 38% increase in obesity risk in adults. The practical consequence is not just increased appetite but a specific pull towards high-carbohydrate, processed foods — the body seeking rapid energy to compensate for fatigue the brain cannot override through willpower alone.

The cortisol connection is particularly pointed here. Cortisol is a glucocorticoid — and rising skeletal glucocorticoid signalling is the same pathway identified as a key driver of leptin resistance in ageing. Poor sleep does not introduce an entirely separate problem; it reinforces the one already running, deepening the hypothalamus's insensitivity to satiety signals and promoting visceral fat storage.

This is where the Biology pillar meets the Chemistry pillar directly. Sleep quality is one of the most accessible levers available in midlife to shift the hormonal environment — not through supplementation or complex protocols, but through a biological process the body is already designed to use.

What you can actually do about it this week

Sleep is the fastest lever, and the lowest barrier to entry. Protecting seven or more hours per night — with consistent timing — directly rebalances ghrelin and leptin: hunger signals fall, satiety sensitivity improves, and the cortisol spike that promotes visceral fat storage weakens across the following day.

Strength training comes next, and it works on more than muscle. Two to three progressive resistance sessions per week preserve the skeletal tissue through which unacylated ghrelin's metabolic benefits operate, while improving the hypothalamic sensitivity to leptin that the ageing process tends to erode. In the Chemistry and Biology pillars of Regeneration by Design — Professor Paul Lee's framework for systemic health design — this is not an aesthetic intervention. It is a systemic one, keeping the body metabolically responsive as the hormonal environment shifts.

Cortisol management has a specific, usable anchor. Five minutes of slow diaphragmatic breathing — four counts in, six counts out — before sleep measurably reduces glucocorticoid tone across the following day, interrupting the signalling pathway that drives leptin resistance. Regularity matters more than duration.

For thyroid health, one direct question at the next relevant blood test is worth more than speculation: could we add free T3 to the panel? Standard results showing TSH and T4 alone may not capture the conversion step where midlife slowdown actually occurs. This is health-design, not self-diagnosis.

Nothing above constitutes medical treatment or individual medical advice; discuss specific health concerns with a qualified professional.

The scales that barely moved despite a disciplined week were not evidence of failure — they were three hormonal systems producing a predictable output. Change the systems, and the number follows.

1. [1] Ghrelin. https://en.wikipedia.org/?curid=768527 https://en.wikipedia.org/?curid=768527
2. [2] Novel Role of Ghrelin Receptor in Gut Dysbiosis and Experimental Colitis in Aging. (2022). https://doi.org/10.3390/ijms23042219 https://doi.org/10.3390/ijms23042219
3. [3] Leptin resistance during aging is independent of fat mass. (2002). https://doi.org/10.2337/DIABETES.51.4.1016 https://doi.org/10.2337/DIABETES.51.4.1016
4. [4] Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice. (2020). https://doi.org/10.1016/j.molmet.2020.101098 https://doi.org/10.1016/j.molmet.2020.101098
5. [5] Leptin. https://en.wikipedia.org/?curid=214938 https://en.wikipedia.org/?curid=214938
6. [6] Single cell analysis of human thyroid reveals the transcriptional signatures of aging. (2023). https://doi.org/10.1210/endocr/bqad029 https://doi.org/10.1210/endocr/bqad029
7. [7] Both ghrelin deletion and unacylated ghrelin overexpression preserve muscles in aging mice. (2020). https://doi.org/10.18632/aging.103802 https://doi.org/10.18632/aging.103802
8. [8] The Aging Thyroid: A Reappraisal Within the Geroscience Integrated Perspective. (2019). https://doi.org/10.1210/er.2018-00170 https://doi.org/10.1210/er.2018-00170